Hi, Shrewd!        Login  
Shrewd'm.com 
A merry & shrewd investing community
Best Of PoliticsBest OfAll BoardsThe Shrewd’m Weekly ¤Learn to InvestHow to Become Shrewd
Search
Shrewd'm.com Merry shrewd investors
Search
Best Of PoliticsBest OfAll BoardsThe Shrewd’m Weekly ¤Learn to InvestHow to Become Shrewd


The week's question
In December 2024, in the thread "Re: BRK: Why Not XOM?", sykesix asked the members: "What do you do if you arrive early at movie besides go to the snack bar?" This week it is put to everyone again. The button below opens the small thread re-asking it - read what others have said so far, then give your own answer as an ordinary reply.
Answer this questionContinue to Shrewd'mThis note won't appear again
Halls of Shrewd'm / US Policy
Unthreaded | Threaded | Whole Thread (1) |
Author: Dope1 ⎊  😊 😞
Number: of 88908 
Subject: What price, price controls?
Date: 11/10/26 4:08 PM
Post New | Post Reply | Report Post | Recommend It!
No. of Recommendations: 2
The WSJ looks into drug pricing controls:

wsj.com - Trumps plan to lower drug prices in u s is leading to fewer new drugs in europe

The Trump administration last year came up with a plan to combat high drug prices—making European governments pay more.

The result so far: still-high drug prices in the U.S. and fewer new drugs in Europe.

There has been a 27% drop in new drug releases across European countries over the last 17 months, compared with the same period before President Trump announced the plan, according to new data from market-research firm GlobalData. Meanwhile, drug approvals in Europe have held steady over that time period.

“You have companies saying, ‘Well maybe I won’t enter the market there because it’s just going to be used against me in the United States,’” said Ipsita Smolinski, director of health-policy research firm Capitol Street.

...
he program is still being rolled out and could eventually lead to lower drug prices. The costs of popular weight loss and infertility drugs have gone down in 2026 as part of the deals with the Trump administration.

Yet some companies have pulled their drugs from certain markets—or didn’t launch in the countries to begin with—so they didn’t have to lower how much they get paid in the U.S. ...

In February, Amgen withdrew a cholesterol-lowering drug from Denmark’s market because of fears that its Danish prices would translate to the U.S. Amgen didn’t respond to requests for comment.

Insmed Chief Executive William Lewis said last year that the company was delaying European launches of its chronic-lung-condition drug because of the U.S. policy. The drug, named Brinsupri, lists for $88,000 a year in the U.S.


Post New | Post Reply | Report Post | Recommend It!
Print the post
Members reply directly to Dope1 here — and replies get answered. Reading is free; so is joining the conversation. Join Shrewd'm »
This community has written 88,852 posts about US Policy. The article-length ones it recommended most:
It's going to get worse · 33 recs · 2025
G’day Donny · 30 recs · 2026
Old Related Story · 28 recs · 2026
HCR is a national treasure · 27 recs · 2025
Fascism in America · 27 recs · 2025
Unthreaded | Threaded | Whole Thread (1) |


Announcements
US Policy FAQ
Contact Shrewd'm
Contact the developer of these message boards.

Best Of Politics | Best Of | Favourites & Replies | All Boards | Followed Shrewds | Open Questions | Moving a community | Privacy